Topiramate Tablet
Product Images NDC 71335-0047

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-0047). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 01

Chemical structure diagram of Topiramate, showing its molecular arrangement with functional groups including a sulfamate moiety and multiple methyl groups attached to a sugar-like ring structure.*

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 02

A chart depicting cumulative rates for time to first seizure over time in days for two dosage groups of Topiramate (50 mg/day and 400 mg/day). The y-axis shows cumulative rates, and the x-axis shows time in days, with two lines indicating differences in seizure occurrence rates between the dosage groups.*

FDA Label Image

Ccb7a1e4 A3a1 4a0e 8eb0 8086f53e314b 03

A bar chart depicting change from baseline to double-blind phase in average weekly migraine period rate (±SE) across 5 groups: Placebo, Topamax 50 mg/day, Topamax 100 mg/day, and Topamax 200 mg/day, from two studies labeled Study 10 and Study 11. Statistical significance is indicated for Topamax 100 mg/day and 200 mg/day compared to placebo.*

FDA Label Image

Label Image (Lbl713350047)

Label for Topiramate 200 mg tablet by Bryant Ranch Prepack. The label includes a comparison to Topamax 200 mg tablet by Cipla Ltd., storage instructions at room temperature (20°-25°C), and a barcode. It indicates a package size of 30 tablets and the NDC number 71335-0047.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.